Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Canc... (

Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology

Date:1/31/2008

- Two Scientific Pioneers Invest in Evolving Field of Protein Homeostasis -

CAMBRIDGE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and Harvard Medical School's Office of Technology Development today announced an innovative collaboration agreement to pursue a research program in the area of protein homeostasis, an emerging and expanding field of cancer biology. Under the terms of the agreement, Harvard has granted Millennium a license to certain invention from the laboratory of Professor J. Wade Harper and the two institutions will jointly advance the program in this novel area of research over several years under a sponsored research agreement. Financial terms were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"Harvard Medical School's research initiatives in protein homeostasis, together with the demonstrated leadership of Millennium in this area, promises to advance our understanding of this important field and its role in regulating cancer cells," said Wade Harper, Ph.D., Bert and Natalie Vallee Professor of Molecular Pathology, Harvard Medical School. "We expect this collaboration to accelerate the important work the lab has accomplished to date."

Research has shown various pathways that regulate cellular protein homeostasis are linked to the pathologic properties of a broad range of cancers. The initial research-based agreement is focused on advancing knowledge in this evolving field over the course of three years.

"Wade Harper's ground-breaking scientific progress in the field of protein homeostasis makes this agreement a natural fit for our Disc
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
2. Millennium to Webcast Business Update in Advance of 26th Annual JPMorgan Healthcare Conference
3. Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
4. Millennium Pharmaceuticals Announces Webcast of American Society of Hematology Investor Event
5. Millennium Biotechnologies Inc. Signs Five Year $20,000,000 Purchase Agreement with Provider Services Inc. of Cleveland, Ohio
6. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
7. 2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation
8. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
9. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
10. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
11. Tips for Dry Winter Skin, From the Harvard Health Letter

Post Your Comments:

Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Canc...( - Two Scientific Pioneers Invest in E...),Health